Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1989-3-28
|
pubmed:databankReference | |
pubmed:abstractText |
YE1/48 is a murine cell surface disulphide-linked dimeric Ag consisting of two 45,000-50,000 Mr subunits. It is expressed on some T lymphoma lines at high levels but its expression on normal lymphocytes is very low. The functional significance of this Ag is currently unknown. We have now cloned a cDNA encoding the YE1/48. Sequence analysis revealed that it encodes a Type II membrane protein of 262 amino acids (30,500 MW), with 44 amino acids in the N-terminal cytoplasmic domain, 22 amino acids in the transmembrane domain and 196 amino acids in the C-terminal extracellular domain. There are three potential N-linked glycosylation sites in the extracellular domain all of which are probably used in the mature protein. No significant homology can be identified with other known protein sequences in the data base or with human CD28(T44), a human T cell activation antigen consisting of two 44,000 Mr subunits. The protein sequence includes in its extracellular domain the arginine-glycine-aspartic acid tripeptide, a potential cell-adhesive binding site, and a sequence similar to the consensus domain of any metal-binding proteins. However, whether these sequences are functional is unknown. Genomic Southern analysis of C57BL/6, BALB/c and C3H mice has demonstrated a restriction fragment length polymorphism. The analysis has also strongly suggested the existence of some other genes with sequences highly homologous to the YE1/48 gene. The YE1/48 gene appears to be expressed at very low levels in a wide range of lymphoid cells with no restriction to their differentiation stages. Interestingly, YE1/48 expression appears to be induced in pre-B cells after transformation by Abelson virus, suggesting an association of YE1/48 expression with the transformation of T and pre-B Cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
142
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1727-36
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2783949-Amino Acid Sequence,
pubmed-meshheading:2783949-Animals,
pubmed-meshheading:2783949-Antigens, Differentiation, T-Lymphocyte,
pubmed-meshheading:2783949-B-Lymphocytes,
pubmed-meshheading:2783949-Base Sequence,
pubmed-meshheading:2783949-Blotting, Northern,
pubmed-meshheading:2783949-Blotting, Southern,
pubmed-meshheading:2783949-Cell Line, Transformed,
pubmed-meshheading:2783949-Cloning, Molecular,
pubmed-meshheading:2783949-DNA,
pubmed-meshheading:2783949-Mice,
pubmed-meshheading:2783949-Mice, Inbred BALB C,
pubmed-meshheading:2783949-Mice, Inbred C3H,
pubmed-meshheading:2783949-Mice, Inbred C57BL,
pubmed-meshheading:2783949-Molecular Sequence Data,
pubmed-meshheading:2783949-Stem Cells,
pubmed-meshheading:2783949-T-Lymphocytes
|
pubmed:year |
1989
|
pubmed:articleTitle |
Molecular cloning and characterization of a novel murine T cell surface antigen, YE1/48.
|
pubmed:affiliation |
Terry Fox Laboratory, B.C. Cancer Research Centre, Vancouver, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|